Adagene Inc. - Ordinary Shares (ADAG)

Historical Holders from Q1 2021 to Q3 2025

Type / Class
Equity / Ordinary Shares
Symbol
ADAG on Nasdaq
Shares outstanding
59,210,526
Price per share
$1.99
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
5,722,260
Holdings value
$11,251,842
% of all portfolios
0%
Share change
-344,072
Value change
-$681,939
Average buys %
+0%
Average sells %
-0%
Number of holders
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adagene Inc. - Ordinary Shares (ADAG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Luo Peter 16% $12,937,369 9,175,439 HAN 2020 Irrevocable Trust 25 Jan 2025
WuXi PharmaTech Healthcare Fund I L.P. 7% -17% $8,187,161 -$1,701,888 4,121,815 -17% WuXi PharmaTech Healthcare Fund I L.P. 30 Sep 2025
Smith Vincent C 6.9% $5,405,666 3,833,806 Smith Vincent C 31 Dec 2024
Panacea Innovation Ltd 3.8% -28% $4,469,175 -$1,564,211 2,250,000 -26% Panacea Venture Healthcare Fund II, L.P. 30 Sep 2025
FIL Ltd 1.8% -75% $1,320,902 -$4,450,930 936,810 -77% FIL Limited 31 Mar 2025
FMR LLC 0.9% $933,679 473,949 FMR LLC 30 Jun 2025
As of 30 Sep 2025, Adagene Inc. - Ordinary Shares (ADAG) has 17 institutional shareholders filing 13F forms. They hold 5,722,260 shares of 59,210,526 outstanding shares (9.7%) .

Institutional Holders of Adagene Inc. - Ordinary Shares (ADAG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,722,260 $11,251,842 -$681,939 $1.99 17
2025 Q2 6,066,432 $11,842,205 -$2,692,639 $1.95 15
2025 Q1 7,596,934 $11,574,144 -$4,448,523 $1.54 13
2024 Q4 10,441,972 $20,299,608 +$6,443,398 $1.99 15
2024 Q3 11,157,880 $25,316,756 -$140,637 $2.22 13
2024 Q2 11,223,549 $33,703,166 -$3,006,648 $3.06 14
2024 Q1 12,297,346 $34,335,526 +$14,585,257 $2.80 17
2023 Q4 5,781,239 $11,163,839 -$2,205,992 $1.93 10
2023 Q3 4,096,719 $6,164,993 -$21,756 $1.53 10
2023 Q2 4,111,294 $6,016,229 -$108,766 $1.48 10
2023 Q1 4,186,071 $6,023,400 -$44,708 $1.45 11
2022 Q4 4,216,842 $5,581,186 -$2,280,668 $1.32 9
2022 Q3 5,940,279 $7,603,000 -$2,338,985 $1.28 11
2022 Q2 7,531,358 $15,421,000 -$3,922,354 $2.03 15
2022 Q1 8,391,600 $29,674,000 -$1,196,241 $3.56 15
2021 Q4 8,373,818 $67,324,000 -$5,705,274 $8.01 16
2021 Q3 8,786,888 $126,610,000 +$41,051,156 $14.37 19
2021 Q2 5,937,931 $80,519,000 -$12,766,604 $13.56 16
2021 Q1 6,435,237 $115,522,000 +$115,522,000 $17.95 27